CAMBRIDGE, Ontario—Custom automation systems manufacturer ATS Life Sciences Systems (ATS LSS) reported that its engineering team is working in collaboration with robotic systems manufacturer Staubli Robotics to build a large-scale syringe assembly system in the eastern United States. The companies are working to create a highly efficient and reliable system—spanning molding systems to end-of-line pack-out—that consistently delivers high quality and performance, according to a release from ATS Life Sciences Systems.
The 300 parts-per-minute, end-to-end syringe assembly system is built on ATS LSS’s high-performance assembly platform. It incorporates eight Staubli robots employed in various operations, including mold unloading, siliconization, tip capping, and robust quality and visual inspections, the company said in the release.
“Staubli and ATS LSS have established a strategic partnership to develop high-end automation projects for the pharma and medical industry,” said Oliver Cremoux, who leads the North American Sales and Marketing team for Duncan, South Carolina-based Staubli Pharma and Med Devices, in the release. “While our companies have collaborated for years, creating state-of-the-art automated solutions for device manufacturing and drug compounding, we are reaching a new milestone with this great success.”
The fully automated syringe assembly system is just one example of an innovative product that can be created by ATS LSS and Staubli Robotics as they work together strategically to meet market demand for medical devices, according to ATS Life Sciences Systems.
“By harnessing the expertise of industry leaders like Staubli and pairing them with the innovative solutions that ATS LSS has become known for, we address our unique customer challenges and continue to drive innovative solutions,” said Andy Glaser, vice president of global sales at ATS Life Sciences Systems, in the release.